Related Experiment Video

Updated: May 5, 2026

Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay
08:13

Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay

Published on: February 20, 2015

12.9K

Molecular genetics and pathogenesis of autosomal dominant polycystic kidney disease

M A Arnaout1

  • 1Renal Unit, Massachusetts General Hospital and Department of Medicine, Harvard Medical School, 149 13th Street, Charlestown, Massachusetts 02129, USA. arnaout@receptor.mgh.harvard.edu

Annual Review of Medicine
|February 13, 2001
PubMed

Insights

Autosomal dominant polycystic kidney disease (ADPKD) arises from cell proliferation, not obstruction. Genetic mutations in PKD1 or PKD2 initiate cyst formation through somatic second hits in kidney cells.

Area of Science:

  • Nephrology
  • Genetics
  • Cell Biology

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is a common systemic disorder.
  • Cyst formation is a key characteristic of ADPKD.
  • Potential causes include obstruction, matrix changes, and cell proliferation, with evidence favoring the latter.

Purpose of the Study:

  • To investigate the primary cellular abnormality driving cyst formation in ADPKD.
  • To elucidate the genetic basis and cellular mechanisms of ADPKD pathogenesis.
  • To understand the role of PKD1 and PKD2 genes in ADPKD development.

Main Methods:

  • Analysis of genetic mutations in PKD1 and PKD2.
  • Investigation of somatic second hit events in epithelial cells.
  • In vitro interaction studies of PKD1 and PKD2 proteins.
  • Examination of cellular and subcellular localization of PKD proteins.

Main Results:

  • Evidence strongly supports cellular proliferation as the primary cause of ADPKD cysts.
  • Mutations in PKD1 or PKD2 are the main genetic causes, acting recessively at the cellular level.
  • Somatic second hits in the normal allele of affected cells initiate or accelerate cyst formation.
  • PKD1 and PKD2 proteins interact and may function in a common signaling pathway.

Conclusions:

  • Cellular proliferation, initiated by somatic second hits in PKD1/PKD2, is the primary driver of ADPKD.
  • The PKD1 and PKD2 proteins are crucial in a signaling pathway regulating cell adhesion, polarity, and potentially cystogenesis.
  • Understanding these mechanisms offers insights into ADPKD pathogenesis and potential therapeutic targets.

More Related Videos

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

10.9K
Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium08:46

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Published on: September 1, 2015

9.2K

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
78.8K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28